V 7 LEU 8 -4.776 -5.147
V 8 THR 4 -4.663 -4.587
V 9 GLU 5 -4.742 -4.772
V 10 TYR 8 -7.324 -7.402
V 11 THR 6 -9.794 -9.357
V 12 LEU 21 -10.940 -12.097
V 13 GLN 5 -12.262 -11.427
V 14 ALA 15 -10.658 -11.157
V 15 ASN 3 -9.425 -8.686
V 16 TRP 5 -7.709 -7.397
V 17 PHE 0 -6.534 -5.782
V 18 ASP 5 -7.329 -7.062
V 19 ILE 11 -7.773 -8.144
V 20 THR 1 -6.525 -5.889
V 21 GLY 7 -6.376 -6.448
V 22 ILE 15 -7.449 -8.317
V 23 LEU 8 -7.108 -7.211
V 24 TRP 6 -6.529 -6.468
V 25 LEU 7 -6.883 -6.896
V 26 LEU 17 -6.839 -8.008
V 27 GLY 7 -5.746 -5.891
V 28 GLN 5 -5.482 -5.426
V 29 VAL 12 -5.796 -6.510
V 30 ASP 2 -5.323 -4.941
V 31 GLY 18 -6.057 -7.431
V 32 LYS 4 -5.555 -5.377
V 33 ILE 13 -6.057 -6.855
V 34 ILE 7 -5.232 -5.436
V 35 ASN 6 -5.130 -5.230
V 36 SER 10 -6.833 -7.197
V 37 ASP 7 -6.714 -6.746
V 38 VAL 4 -7.152 -6.789
V 39 GLN 10 -9.228 -9.317
V 40 ALA 0 -10.478 -9.273
V 41 PHE 12 -12.608 -12.538
V 42 VAL 3 -13.930 -12.673
V 43 LEU 6 -15.183 -14.127
V 44 LEU 8 -15.800 -14.903
V 45 ARG 2 -14.978 -13.485
V 46 VAL 16 -15.446 -15.510
V 47 ALA 0 -14.590 -12.912
V 48 LEU 13 -14.313 -14.162
V 49 PRO 3 -12.021 -10.984
V 50 ALA 1 -12.428 -11.114
V 51 ALA 0 -11.104 -9.827
V 52 LYS 7 -12.705 -12.049
V 53 VAL 11 -14.959 -14.503
V 54 ALA 1 -13.603 -12.154
V 55 GLU 6 -12.752 -11.976
V 56 PHE 12 -15.264 -14.889
V 57 SER 10 -15.570 -14.930
V 58 ALA 6 -13.853 -12.950
V 59 LYS 5 -13.307 -12.352
V 60 LEU 14 -15.197 -15.059
V 61 ALA 9 -14.272 -13.666
V 62 ASP 6 -11.368 -10.751
V 63 PHE 9 -11.963 -11.622
V 64 SER 11 -13.526 -13.235
V 65 GLY 0 -10.039 -8.884
V 66 GLY 0 -12.852 -11.374
V 67 SER 6 -13.238 -12.406
V 68 LEU 20 -15.980 -16.442
V 69 GLN 4 -16.288 -14.875
V 70 LEU 17 -17.407 -17.360
V 71 LEU 7 -16.279 -15.212
V 72 ALA 5 -15.405 -14.208
V 73 ILE 8 -13.524 -12.889
V 74 GLU 1 -9.930 -8.903

Identified 0 B-Cell epitope residues out of 68 total residues